Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 2239273-34-6 Chemical Structure| 2239273-34-6

Structure of Etrumadenant
CAS No.: 2239273-34-6

Chemical Structure| 2239273-34-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

AB928 is a dual A2aR/A2bR antagonist that inhibits A2aR and A2bR with an equilibrium binding constant of 1.4 and 2 nM, respectively.

Synonyms: AB928; A2aR/A2bR antagonist-1

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Etrumadenant

CAS No. :2239273-34-6
Formula : C23H22N8O
M.W : 426.47
SMILES Code : N#CC1=CC=CC(C2=NC(N)=NC(C3=CN(CC4=NC(C(C)(O)C)=CC=C4)N=N3)=C2)=C1C
Synonyms :
AB928; A2aR/A2bR antagonist-1
MDL No. :N/A
InChI Key :BUXIAWLTBSXYSW-UHFFFAOYSA-N
Pubchem ID :135242184

Safety of Etrumadenant

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301+H311+H331-H315-H319
Precautionary Statements:P261-P264-P270-P271-P280-P301+P310+P330-P302+P352+P312+P361+P364-P304+P340+P311-P305+P351+P338+P337+P313-P403+P233-P405-P501
Class:6.1
UN#:2811
Packing Group:

Related Pathways of Etrumadenant

GPCR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
CHO-A2aR cells 10 µM 30 minutes To evaluate the selectivity of DZD2269 for A2aR and its ability to inhibit cAMP accumulation. Results showed DZD2269 effectively inhibited cAMP accumulation stimulated by 10 µM NECA. J Exp Clin Cancer Res. 2022 Oct 14;41(1):302
SUIT-2-MSLN 10 nM to 1 μM 24 hours Assess the effect of AB928 on human anti-MSLN CAR T cells, demonstrating AB928 restored IFN-γ and IL-2 secretion inhibited by NECA. Br J Cancer. 2022 Dec;127(12):2175-2185
4T1, LL/2-EpCAM, T110299-EpCAM, CT26-EpCAM 100 nM 24 hours Validate the protective effect of AB928 on CAR T cell function across different cancer cell lines, showing AB928 reversed NECA-mediated suppression in all cell lines. Br J Cancer. 2022 Dec;127(12):2175-2185
Panc02-EpCAM 100 nM to 10 μM 24 hours Evaluate the impact of AB928 on CAR T cell cytokine secretion, finding that AB928 fully restored IFN-γ, IL-2, and TNF-α secretion inhibited by NECA. Br J Cancer. 2022 Dec;127(12):2175-2185

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c mice Colon carcinoma model Oral 10 mg Once daily until the end of the experiment Evaluate the effect of oral AB928 on CAR T cell activation, showing AB928 enhanced CAR T cell activation and promoted an effector-like phenotype. Br J Cancer. 2022 Dec;127(12):2175-2185

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT05277012 Healthy Participants PHASE1 COMPLETED 2022-03-31 Investigational Site, Lincoln,... More >> Nebraska, 68502, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.34mL

0.47mL

0.23mL

11.72mL

2.34mL

1.17mL

23.45mL

4.69mL

2.34mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories